Engineers Gate Manager’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-53,982
Closed -$805K 2337
2023
Q3
$805K Buy
+53,982
New +$716K 0.03% 823
2021
Q3
Sell
-10,989
Closed -$48K 2061
2021
Q2
$48K Buy
10,989
+296
+3% +$1.31K ﹤0.01% 1547
2021
Q1
$49K Buy
+10,693
New +$57.5K ﹤0.01% 1747
2020
Q3
Sell
-59,912
Closed -$209K 2047
2020
Q2
$209K Buy
59,912
+42,239
+239% +$122K 0.01% 1428
2020
Q1
$26K Sell
17,673
-69,887
-80% -$117K ﹤0.01% 1511
2019
Q4
$172K Buy
87,560
+48,067
+122% +$181K 0.01% 1496
2019
Q3
$202K Sell
39,493
-172,647
-81% -$1.05M 0.01% 1201
2019
Q2
$1.52M Buy
212,140
+120,487
+131% +$1.36M 0.08% 385
2019
Q1
$1.22M Buy
91,653
+31,714
+53% +$337K 0.07% 389
2018
Q4
$472K Buy
+59,939
New +$571K 0.04% 541

Other funds holding CBAY